Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
批准号:
8746604
负责人:
GRIFFIN RODGERS
金额:
$38.54万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Amino Acid SequenceApoptosisAspergillus fumigatusAttenuatedBacterial InfectionsCSF3 geneCXCL2 geneCathepsin CCathepsin GChronic Granulomatous DiseaseCytoplasmic GranulesDisease modelEpitheliumGenesGlycoproteinsGoalsGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorHematopoieticHost DefenseHumanIL6 geneImmuneIn VitroInfectionInflammationInflammatoryInflammatory Bowel DiseasesInterferonsInterleukin-1Interleukin-12LaboratoriesLeukocyte ElastaseLifeLinkLungMalignant NeoplasmsMediatingMicrobeModelingMucous MembraneMusMycosesMyelogenousNatural ImmunityNoelin-1Pathway interactionsPatientsPeptide HydrolasesPeptide Sequence DeterminationPlayProteinsRecurrenceRegulationReportingResistanceRoleSepsisSerumSignal TransductionStaphylococcus aureusSystemic infectionTranslationsTretinoinalpha-latrotoxin receptorchemokinecytokinegastrointestinal infectionimprovedin vivokillingsneutrophilolfactomedinprecursor cell
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chronic granulomatous disease (CGD) patients have recurrent life-threatening bacterial and fungal infections. Olfactomedin 4 (OLFM4) is a neutrophil granule protein that negatively regulates host defense against bacterial infection. The goal of this study was to evaluate the impact of Olfm4 deletion on host defense against Staphylococcus aureus and Aspergillus fumigatus in a murine X-linked CGD model. Here we hypothesize that deletion of Olfm4 in CGD neutrophils may restore microbe-killing activities through nonoxidative mechanisms.
We have shown that intracellular killing and in vivo clearance of S. aureus, as well as resistance to S. aureus sepsis, were significantly increased in gp91phox and Olfm4 double-deficient mice compared with CGD mice. Activities of cathepsin C and its downstream proteases (neutrophil elastase and cathepsin G) and serum levels of IL1β, IL6, IL12 p40, CXCL2, G-CSF, and GM-CSF in Olfm4-deficient as well as gp91phox and Olfm4 double-deficient mice were significantly higher than those in WT as well as CGD mice after challenged with S. aureus. However, we did not observe enhanced defense against A. fumigatus in Olfm4-deficient mice using a lung-infection model. These results show that Olfm4 deletion can successfully enhance immune defense against S. aureus, but not A. fumigatus in CGD mice. To determine whether the effect of Olfm4 deletion on S. aureus immune defense is mediated through the TLR-MyD88 pathway, we investigated the host defense of MyD88 and Olfm4 double-deficient mice against S. aureus systemic infection. While the MyD88 deficient mice were highly susceptible to S. aureus infection, additional Olfm4 elimination remarkably improved the survival of MyD88-deficient mice and enhanced the serum levels of some NF-κB targeted pro-inflammatory cytokines and chemokines. These results suggest that enhanced mouse innate immunity due to Olfm4 deletion is TLR-MyD88 signal independent, and that NOD-mediated NF-κB may play an important role.
Taken together, we found that deletion of Olfm4, a critical negative regulator of neutrophil protease activities and the NOD-mediated pathway, could enhance the immune defense against S. aureus infection in CGD mice. This finding provides a rationale to enhance CGD patient defense against bacterial infections potentially through the modulation of OLFM4 levels. OLFM4 might prove to be an important target in CGD patients to augment host defense against bacterial infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
-
批准号:8557968
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
-
批准号:8557970
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8939812
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
-
批准号:8149534
-
项目类别:
-
资助金额:$69.25万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
-
批准号:8149535
-
项目类别:
-
资助金额:$69.25万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:9157363
-
项目类别:
-
资助金额:$56.41万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
-
批准号:8344821
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:8557967
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:8939810
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:9357228
-
项目类别:
-
资助金额:$58.81万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 is a key regulator of human neutrophil function
-
批准号:10012677
-
项目类别:
-
资助金额:$52.01万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10253822
-
项目类别:
-
资助金额:$40.45万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 is a key regulator of colon cancer progression
-
批准号:8939811
-
项目类别:
-
资助金额:$32.92万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8344822
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:8344820
-
项目类别:
-
资助金额:$83.2万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Effects Of Thalidomide and Stem Cell Factor On Fetal Hemoglobin Synthesis
-
批准号:7969153
-
项目类别:
-
资助金额:$34.29万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
-
批准号:8746605
-
项目类别:
-
资助金额:$38.54万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10706165
-
项目类别:
-
资助金额:$59.52万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4- a key regulator of human neutrophil function, role in small intestinal adenocarcinoma.
-
批准号:10253823
-
项目类别:
-
资助金额:$40.45万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
-
批准号:10929107
-
项目类别:
-
资助金额:$64.05万
-
财政年份:--
-
负责人:GRIFFIN RODGERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: